MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.neurot.2025.e00741

Медицинская библиотека · Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025

Rescue of neurologic disease in mucopolysaccharidosis type II mice via AAV-mediated liver delivery of brain-penetrating iduronate-2-sulfatase.

Jin Xiu, Ye Qin, Wu Xiaoyi, Su Jing, Song Li, Fu Jiamei, Xu Qiuxia, Luo Min, Liu Fanfei, Ren Chengda, Hu Ming, Liu Man, An Yifang, Li Qiqi, Li Manjun, Yang Yang

СтатьяПеревод в очереди

Аннотация

Mucopolysaccharidosis type II (MPS II) is a neurodegenerative lysosomal storage disorder (LSD) caused by inherited mutations in the iduronate-2-sulfatase (IDS) gene. Approximately two-thirds of patients exhibit severe central nervous system (CNS) involvement and cognitive impairment, which remain unaddressed by conventional enzyme replacement therapy (ERT) due to the inability of wild-type IDS to cross the blood-brain barrier (BBB). To overcome this limitation, we engineered a brain-penetrant IDS variant, eBT-IDS4, which retained enzymatic activity and demonstrated enhanced BBB transcytosis in vitro. We then evaluated a liver-directed gene therapy approach using an adeno-associated virus 8 (AAV8) vector encoding eBT-IDS4 under the control of a liver-specific promoter (LSP) in an adult MPS II mouse model. Intravenous administration of AAV8.LSP.IVS2.eBT-IDS4 resulted in sustained supraphysiological IDS activity and normalization of glycosaminoglycan (GAG) levels in peripheral tissues. Notably, this strategy achieved 89 ​% of wild-type IDS activity in the brain, leading to complete correction of neuropathology and reversal of cognitive deficits in 8-month-old MPS II mice. These findings support a promising, minimally invasive gene therapy strategy for treating MPS II and other neurodegenerative LSDs.

Для цитирования: Jin Xiu, Ye Qin, Wu Xiaoyi, Su Jing, Song Li, Fu Jiamei, Xu Qiuxia, Luo Min, Liu Fanfei, Ren Chengda, Hu Ming, Liu Man, An Yifang, Li Qiqi, Li Manjun, Yang Yang. Rescue of neurologic disease in mucopolysaccharidosis type II mice via AAV-mediated liver delivery of brain-penetrating iduronate-2-sulfatase.. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2025. DOI: 10.1016/j.neurot.2025.e00741.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.